Literature DB >> 7014228

Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.

J Carmo-Pereira, F O Costa, E Henriques.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7014228     DOI： 10.1016/0014-2964(80)90037-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  A randomized trial of two regimens of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone in advanced breast cancer.

Authors:  J Carmo-Pereira; F O Costa; E Henriques; V Carvalho
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds.

Authors:  Denis L Jardim; Débora De Melo Gagliato; Mina Nikanjam; Donald A Barkauskas; Razelle Kurzrock
Journal:  Oncoimmunology       Date:  2020-01-13       Impact factor: 8.110

Review 3.  Single agent versus combination chemotherapy for metastatic breast cancer.

Authors:  Sue Carrick; Sharon Parker; Charlene E Thornton; Davina Ghersi; John Simes; Nicholas Wilcken
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.